PAR:EMEIS

Emeis · PAR · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 13:43 UTC

Last close

n/aEUR

Market data

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -5.1%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 8.7%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 6.11Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed

All from 100

lens 2 of 9

Sales

207
2016-12-31 to 2025-12-31100 at the start207
Sales: 100.00 on 2016-12-31 to 207.49 on 2025-12-31, up 107%.

Profit

-102
2016-12-31 to 2025-12-31100 at the start-102
Profit: 100.00 on 2016-12-31 to -101.66 on 2025-12-31, down 202%.

Shares in issue

267
2016-12-31 to 2025-12-31100 at the start267
Shares in issue: 100.00 on 2016-12-31 to 267.44 on 2025-12-31, up 167%.

Sales is at 208, Profit is at -102, Shares in issue is at 267, against 100 in 2016.

Sales is at 208, Profit is at -102, Shares in issue is at 267, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales, where the first year is 100208
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Profit, where the first year is 100-102
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Shares in issue, where the first year is 100267
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.